Gallery
Picture 1
Tempus stock forecast active traders note Tempus stock
New with box
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Active traders note Tempus stock forecast momentum aligning with biotech index strength. A sustained close above $45 could trigger algorithmic buying flows and accelerate technical rally patterns. Yet, despite the company’s several long-term upsides, the lower-than-expected fourth-quarter performance was a disappointment. Its expensive valuation is limiting this Zacks Rank #3 (Hold) stock’s near-term gains. While current shareholders should hold their positions, new investors should wait for the stock to retract some of its recent gains, providing a better entry point. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here . Additionally, the executive order could lead to new partnerships, grants, or government-backed projects, giving Tempus AI more opportunities to grow its AI healthcare solutions. Hedge fund positioning aligns with a positive Tempus stock forecast, as several funds increased exposure by double-digit percentages in the latest SEC filings.